RECK overexpression reduces invasive ability in ameloblastoma cells

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Ameloblastoma is a common, locally invasive odontogenic neoplasm with a high recurrence rate.
• Reversion-inducing cysteine-rich protein with Kazal motifs (RECK) is a known tumor suppressor inhibiting metastasis and angiogenesis.
• Investigating RECK's role in ameloblastoma invasiveness is crucial for understanding tumor progression.

Purpose of the Study:

• To examine the impact of RECK gene overexpression on the invasive potential of ameloblastoma cells.
• To assess the effects of RECK on cell proliferation, migration, and invasion.
• To analyze the regulation of matrix metalloproteinases (MMP)-2 and MMP-9 by RECK in ameloblastoma.

Main Methods:

• Stable transfection of immortalized ameloblastoma cells (hTERT(+) -AM) with lentiviral vectors carrying the human RECK gene.
• Assessment of cell proliferation, migration, and invasion using standard assays.
• Quantification of MMP-2 and MMP-9 activity via zymography and commercial assays.

Main Results:

• RECK mRNA and protein expression were significantly upregulated in transfected cells (P < 0.01).
• RECK overexpression markedly decreased ameloblastoma cell migration and invasion (P < 0.01).
• Activity of MMP-2 and MMP-9 was significantly reduced following RECK overexpression (P < 0.01), while proliferation remained unaffected (P > 0.05).

Conclusions:

• Overexpression of the RECK gene significantly inhibits the invasive capabilities of ameloblastoma cells.
• RECK demonstrates potential as a novel therapeutic target for managing ameloblastoma.
• Further research into RECK's therapeutic applications in ameloblastoma is warranted.